October 2026 · Highlight · 29 AIXC papers accepted at NeurIPS 2026 across 10 workshops View publications →
Independent AI Research Lab

29 Papers at NeurIPS 2026 Workshops.
100+ Accepted Across 10+ Venues.
Alongside Google DeepMind and OpenAI.

Our key application is Alzheimer's reversal, within the broader area of drug design and biological discovery. Research validated at the world's most selective technical conferences — NeurIPS, AAAI, Stanford, and ELLIS. Founded by a former META EVP and AI researcher since the 1990s.

29 NeurIPS 2026 workshops
100+ papers accepted
16 AAIC 2026 posters
15 AD/PD 2027 accepted
5 oral presentations
6 platforms

Two engines. Every domain.

Foundational architectures that transfer across disciplines — from molecular dynamics to regulatory compliance.

ACHT Active Causal Hypothesis Testing

Integrates Bayesian Optimization with Generative AI and Causal Discovery to autonomously formulate, test, and refine scientific hypotheses. Reduces wet-lab iteration cycles by orders of magnitude.

Bayesian Optimization Generative AI Causal Discovery Active Learning

VAP Verified Agentic Pipeline

Polyculture agent ensembles with built-in self-falsification and physics-informed surrogates. Every claim is verified against ground truth before propagation, eliminating hallucination cascades.

Polyculture Agents Self-Falsification Physics-Informed Surrogates Formal Verification

One architecture, four frontiers

The same core methodology — validated independently in each domain with peer-reviewed results.

Bio / Pharma

Accelerating drug discovery from target identification through lead optimization. ACHT-driven molecular generation with causal ADMET prediction.

92% fewer experiments (AAAI 2026 oral)
9 papers published

Financial AI

Echo chamber detection, causal risk propagation, and verified portfolio construction. Separating signal from herding in markets.

Echo chamber detection
5 papers published

Legal Tech

Neuro-symbolic regulation models combining formal logic with LLM reasoning. Automated compliance verification with provenance tracking.

Neuro-symbolic models
3 papers published

Materials Science

Physics-informed surrogates for crystal structure prediction, alloy optimization, and ceramic formulation with DFT-validated accuracy.

100-1,000x acceleration
3+ papers published

Peer-reviewed. Reproducible.

Selected papers from top-tier venues. Full list on the publications page.

AAAI-26 Oral

Active Causal Hypothesis Testing with Bayesian Generative Models for Drug Discovery

ACHT Framework · Oral Presentation (top ~1% acceptance rate)

AAAI-26 Oral

Verified Agentic Pipelines: Self-Falsification in Multi-Agent Scientific Discovery

VAP Architecture · Formal verification for agentic systems

NeurIPS

Physics-Informed Surrogate Models for Materials Property Prediction with Causal Guarantees

Materials Science Track · 100-1,000x acceleration over DFT

Stanford

Echo Chamber Detection in Financial Markets via Causal Information Flow

Stanford AI+Finance Workshop · Causal herding identification

AAAI-26

Neuro-Symbolic Regulatory Compliance: Bridging Formal Logic and LLM Reasoning

AI & Law Track · Automated regulation verification

ELLIS

Domain-Agnostic Self-Falsification: A Universal Framework for Trustworthy AI-Driven Research

ELLIS Workshop on Reliable AI · Cross-domain methodology


AAAI
NeurIPS
Stanford
ELLIS
ICLR
IEEE
IROS
CIKM
ISMB
Google Scholar Top 3

84 papers at top-venue workshops

Our research is validated at the same conferences where Google DeepMind, OpenAI, and leading university labs publish their most advanced work.

29
29 papers accepted across 10 NeurIPS 2026 workshops
#1 Google Scholar h5: 337
All 29 papers →
16
16 abstracts · In-Person Posters · all certified by the Alzheimer's Association
London · Alzheimer's Association
15
15 accepted abstracts · Barcelona, March 2027
Alzheimer's & Parkinson's Diseases
11+
4 workshops, 2 oral presentations
#3 Google Scholar h5
View workshop →
~14
4 workshop tracks · April 2026 · Rio de Janeiro
#2 Google Scholar h5: 304
Official site →
1
Agents4Science Workshop
Nobel laureate on board
Stanford site →
6
Applied AI for science, 2 oral
Applied AI conference
3+
FinAI & GMLLM workshops
ACM top-tier venue
Workshop →
1
ML4Molecules Workshop
European ML excellence
Workshop →
3
Alzheimer's & drug discovery focus
ICLR-affiliated
Publishing alongside: Google DeepMind OpenAI Meta FAIR Microsoft Research Stanford MIT CMU
Founded by David Scott Lewis · AI Researcher Since the 1990s · Former META EVP · Stanford Affiliate

Our Team at the World's
Most Selective Venues

From paper to product

Six platforms translating research into real-world impact — each validated against domain benchmarks.

Drug Discovery
ACHT-powered

End-to-end molecular generation with causal ADMET filtering and synthesis planning.

Research Automation
VAP-driven

Multi-agent literature review, hypothesis generation, and experimental design.

AI-Scientist
3,000x acceleration

Autonomous scientific discovery with formal verification and reproducibility guarantees.

Ceramics
Materials AI

Surrogate-accelerated ceramic formulation and firing profile optimization.


“Peer-Reviewed.
Production-Deployed.
”

Every method is validated through peer review before deployment. We believe scientific acceleration requires institutional-grade rigour with the speed and focus of an independent research lab. Founded by a former META EVP. Revenue-generating across drug discovery and financial AI.

Reproducibility First
Research Tools
Self-Falsification
Domain-Agnostic

A Cross-Domain AI Research Lab
Ready to Scale

AIXC Research offers rare horizontal AI capabilities spanning drug discovery, financial markets, and materials science — backed by 100+ accepted peer-reviewed papers, including 29 at NeurIPS 2026 workshops plus AAAI and ICLR workshops, 6 production-deployed platforms, and a team founded by a former META EVP. Our key application is Alzheimer's reversal, within the broader area of drug design and biological discovery. We welcome acquisition discussions, technology licensing, and strategic research partnerships.

100+ Peer-Reviewed Papers
6 Production Platforms
4 Research Domains
Former META EVP
Revenue Generating
Contact Corp Dev Team

Acquisition inquiries · Technology licensing · Joint research · Strategic investment

Explore our platforms

From molecular discovery to climate science — explore the platforms built on ACHT and VAP.